233 related articles for article (PubMed ID: 25690319)
1. Tenascin-C induces resistance to apoptosis in pancreatic cancer cell through activation of ERK/NF-κB pathway.
Shi M; He X; Wei W; Wang J; Zhang T; Shen X
Apoptosis; 2015 Jun; 20(6):843-57. PubMed ID: 25690319
[TBL] [Abstract][Full Text] [Related]
2. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin in combination with bergamottin potentiates TNF-induced apoptosis through modulation of NF-κB signalling pathway in human chronic myelogenous leukaemia.
Kim SM; Lee EJ; Lee JH; Yang WM; Nam D; Lee JH; Lee SG; Um JY; Shim BS; Ahn KS
Pharm Biol; 2016 Oct; 54(10):2050-60. PubMed ID: 26911804
[TBL] [Abstract][Full Text] [Related]
4. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation.
Wei WT; Chen H; Ni ZL; Liu HB; Tong HF; Fan L; Liu A; Qiu MX; Liu DL; Guo HC; Wang ZH; Lin SZ
Int J Oncol; 2011 Dec; 39(6):1381-90. PubMed ID: 21805032
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine resistance induced by interaction between alternatively spliced segment of tenascin-C and annexin A2 in pancreatic cancer cells.
Gong XG; Lv YF; Li XQ; Xu FG; Ma QY
Biol Pharm Bull; 2010; 33(8):1261-7. PubMed ID: 20686216
[TBL] [Abstract][Full Text] [Related]
6. Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation.
Yadav V; Varshney P; Sultana S; Yadav J; Saini N
BMC Cancer; 2015 Aug; 15():581. PubMed ID: 26260159
[TBL] [Abstract][Full Text] [Related]
7. Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathway.
Paron I; Berchtold S; Vörös J; Shamarla M; Erkan M; Höfler H; Esposito I
PLoS One; 2011; 6(6):e21684. PubMed ID: 21747918
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer.
Banerjee S; Zhang Y; Wang Z; Che M; Chiao PJ; Abbruzzese JL; Sarkar FH
Int J Cancer; 2007 Feb; 120(4):906-17. PubMed ID: 17131310
[TBL] [Abstract][Full Text] [Related]
9. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
10. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis.
Esposito I; Penzel R; Chaib-Harrireche M; Barcena U; Bergmann F; Riedl S; Kayed H; Giese N; Kleeff J; Friess H; Schirmacher P
J Pathol; 2006 Apr; 208(5):673-85. PubMed ID: 16450333
[TBL] [Abstract][Full Text] [Related]
11. Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C.
Li J; Xiang S; Zhang Q; Wu J; Tang Q; Zhou J; Yang L; Chen Z; Hann SS
J Exp Clin Cancer Res; 2015 May; 34(1):46. PubMed ID: 25971429
[TBL] [Abstract][Full Text] [Related]
12. Trichothecin induces cell death in NF-κB constitutively activated human cancer cells via inhibition of IKKβ phosphorylation.
Su J; Zhao P; Kong L; Li X; Yan J; Zeng Y; Li Y
PLoS One; 2013; 8(8):e71333. PubMed ID: 23936501
[TBL] [Abstract][Full Text] [Related]
13. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.
Ling MT; Wang X; Ouyang XS; Xu K; Tsao SW; Wong YC
Oncogene; 2003 Jul; 22(29):4498-508. PubMed ID: 12881706
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism(s) of actinomycin-D induced sensitization of pancreatic cancer cells to CD95 mediated apoptosis.
Glazyrin AL; Chinni S; Alhasan S; Adsay VN; Vaitkevicius VK; Sarkar FH
Int J Oncol; 2002 Jan; 20(1):201-5. PubMed ID: 11743665
[TBL] [Abstract][Full Text] [Related]
15. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
[TBL] [Abstract][Full Text] [Related]
16. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis.
Kim HS; Chang I; Kim JY; Choi KH; Lee MS
Cancer Res; 2005 Jul; 65(14):6111-9. PubMed ID: 16024612
[TBL] [Abstract][Full Text] [Related]
17. pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression.
Wang M; Lu X; Dong X; Hao F; Liu Z; Ni G; Chen D
World J Surg Oncol; 2015 Feb; 13():66. PubMed ID: 25880226
[TBL] [Abstract][Full Text] [Related]
18. High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis.
Weichert W; Boehm M; Gekeler V; Bahra M; Langrehr J; Neuhaus P; Denkert C; Imre G; Weller C; Hofmann HP; Niesporek S; Jacob J; Dietel M; Scheidereit C; Kristiansen G
Br J Cancer; 2007 Aug; 97(4):523-30. PubMed ID: 17622249
[TBL] [Abstract][Full Text] [Related]
19. Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells.
Wu LF; Li GP; Su JD; Pu ZJ; Feng JL; Ye YQ; Wei BL
Biochem Cell Biol; 2010 Aug; 88(4):705-14. PubMed ID: 20651843
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer.
Nakashima H; Nakamura M; Yamaguchi H; Yamanaka N; Akiyoshi T; Koga K; Yamaguchi K; Tsuneyoshi M; Tanaka M; Katano M
Cancer Res; 2006 Jul; 66(14):7041-9. PubMed ID: 16849549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
